Immunotherapy: Understanding Safety and Pharmacology
Description
Cancer immunotherapy attempts to stimulate the immune system to destroy cancer cells. Recently Immunotherapy became of great interest to the scientific community, since it was found particularly promising to treat cancer and it represents the most targeted therapy of all. Authors offering original research articles, review papers featuring timely issues or topics are invited to submit. Topics spanning immunotherapy may include but are not limited to: Antibody-based therapy to treat cancer. CAR T-Cell Therapies. Immune checkpoint inhibitors to treat cancer. Cancer vaccines. Editors encourage discussion on evaluation of safety and pharmacology of immunotherapy.
Guest Editors
| Name | Affiliation |
| Miriam Canavese | Scientific Director and Head of Immuno-Pharmacology, Freeline Therapeutics, UK |
| Micaela Harrasser | Researcher, University College London, UK |
Important Dates
| Manuscript Submission Deadline | August 31, 2020 |
| Review Completed by | October 15, 2020 |
| Possible Publication Date | November 30, 2020 |